Neurofibromatosis type 1 and primary hyperparathyroidism with spinal deformity and osteoporosis

Acta Chirurgica Belgica

Volumn 109, Issue 1, 2009, Pages 123-125

  Bahadir, C ^a   Gurleyik G ^a,b   Ocak, F ^a  

^a Department of Physical Medicine and Rehabilitation ^*  (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hyperparathyroidism; Neurofibromatosis; Osteoporosis; Scoliosis

Indexed keywords

EID: 62249215712     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2009.11680390     Document Type: Article

References (10)

1. SANTOS C. C., MILLER V. S., ROACH E. S. Neurocutaneous Syndromes. In: BRADLEY W. G., DAROFF R. B., FENICHEL G. M., JANKOVIC J. (eds). Neurology in Clinical Practice - The Neurological Disorders. 4th Edition. Philadelphia: Elsevier Saunders 2004:1873-1877.
2. CINAMON U., AVINOACH I., HARELL M. Neurofibromatosis type 1, hyperparathyroidism, and osteosarcoma: interplay? Eur Arch Otorhinolaryngol, 2002, 259 (10): 540-542.
3. KEARNS A. E., TOMPSON G. B. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc, 2002, 77: 87-91.
4. MOITON M. P., BUOU F., VARGAS F., VALENTINO R., GRUSON D., HILBERT G., BENISSAN G., CARDINAUD J. P. Association of type 1 neurofibromatosis and primary hyperparathyroidism. Presse Med, 2002, 31: 1604-5.
5. DUQUENNE M., KLEIN M., DUIEZ T., HADJADI S., WERYHA G., LECLERE J. Hyperparathyroidism in a patient with neurofibromatosis associated with Steinert's disease. Ann Med Interne, 1994, 145: 505-507.
6. CHAKRABARTI S., MURUGESAN A., ARIDA E. J. The association of neurofibromatosis and hyperparathyroidism. Am J Surg, 1979, 137: 417-420.
7. CARNEY J. A. Familial multiple endocrine neoplasia: the first 100 years. Am J Surg Pathol, 2005, 29: 254-274.
8. KUORILEHTO T., POYHONEN M., BLOIQU R., HEIKKINEN J., VAANANEN K., PELTONEN J. Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int, 2005, 16: 928-936.
9. WU X., ESTWICK S. A., CHEN S., YU M., MING W., NEBESIO T. D., LI Y., YUAN J., KAPUR R., INGRAM D., YODER M. C., YANG F. C. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. Hum Mol Genet, 2006, 15: 2837-2845.
10. ABDEL-WANIS M. E., KAWAHARA N., TOMITA K. The association of neurofibromatosis 1 and spinal deformity with primary hyperparathyroidism and osteomalacia : might melatonin have a role? J Orthop Sci, 2001, 6: 193-198.